Characterization of a granule-independent lytic mechanism used by CTL hybridomas - PubMed (original) (raw)
. 1994 Dec 15;153(12):5413-21.
Affiliations
- PMID: 7527440
Characterization of a granule-independent lytic mechanism used by CTL hybridomas
R Garner et al. J Immunol. 1994.
Abstract
The mechanism(s) by which CTL induce target cell lysis have not been clearly elucidated. Perforin and the cytotoxic cell proteinases (granzymes) contained within the granules of CTL and NK, have been implicated, but abundant evidence for the existence of alternate lytic pathways has accumulated. In this report we characterize the mechanism of killing used by two cytolytic hybridomas (PMM-1 and MD90) that express neither perforin nor the granzymes. These characteristics are compared with results obtained by using a representative Ag-dependent, granule-containing T cell clone in cytolysis assays. The major differences were that the granule-negative hybridomas could lyse a variety of target cells in the presence of cyclosporin and the absence of calcium. All the effectors could kill in the presence of protein synthesis inhibitors (cycloheximide and emetine) and induced DNA fragmentation in the target cells. The cytolytic hybridomas had to be stimulated to be cytolytic and this activation required the presence of calcium, was dependent on protein synthesis, and inhibited by the addition of cyclosporin. Although TNF was shown not be involved, the sensitivity of the target cells to lysis by the granule-negative killers correlated with the level of expression of Fas Ag. With the use of L1210 and an L1210 cell line transfected with Fas cDNA we demonstrated that these MD90 and PMM-1 kill the latter much more effectively and that this increase was effectively inhibited with anti-Fas Ab. Furthermore the lack of sensitivity to cyclosporin, cycloheximide, emetine, and EGTA was confirmed with these targets. We conclude that these two cytolytic hybridomas use the Fas lytic pathway to induce lysis in target cells.
Similar articles
- The role of the Fas lytic pathway in a perforin-less CTL hybridoma.
Walsh CM, Glass AA, Chiu V, Clark WR. Walsh CM, et al. J Immunol. 1994 Sep 15;153(6):2506-14. J Immunol. 1994. PMID: 7521365 - Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
Berke G, Rosen D, Ronen D. Berke G, et al. Immunology. 1993 Jan;78(1):105-12. Immunology. 1993. PMID: 8436395 Free PMC article. - Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ, Norihisa Y, Ortaldo JR. Smyth MJ, et al. J Immunol. 1992 Jan 1;148(1):55-62. J Immunol. 1992. PMID: 1345790 - Involvement of granule proteins in T-cell-mediated cytolysis.
Krähenbühl O, Tschopp J. Krähenbühl O, et al. Nat Immun Cell Growth Regul. 1990;9(4):274-82. Nat Immun Cell Growth Regul. 1990. PMID: 2215515 Review. - The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects.
Berke G. Berke G. Annu Rev Immunol. 1994;12:735-73. doi: 10.1146/annurev.iy.12.040194.003511. Annu Rev Immunol. 1994. PMID: 8011296 Review.
Cited by
- Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells.
Matera L, Beltramo E, Martinuzzi E, Buttiglieri S. Matera L, et al. Clin Exp Immunol. 2004 Aug;137(2):320-8. doi: 10.1111/j.1365-2249.2004.02533.x. Clin Exp Immunol. 2004. PMID: 15270849 Free PMC article. - The molecular biology of apoptosis.
Vaux DL, Strasser A. Vaux DL, et al. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2239-44. doi: 10.1073/pnas.93.6.2239. Proc Natl Acad Sci U S A. 1996. PMID: 8637856 Free PMC article. Review. - Decreased tumor surveillance in perforin-deficient mice.
van den Broek ME, Kägi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, Zinkernagel RM, Hengartner H. van den Broek ME, et al. J Exp Med. 1996 Nov 1;184(5):1781-90. doi: 10.1084/jem.184.5.1781. J Exp Med. 1996. PMID: 8920866 Free PMC article. - Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo.
Meiraz A, Garber OG, Harari S, Hassin D, Berke G. Meiraz A, et al. Immunology. 2009 Sep;128(1):69-82. doi: 10.1111/j.1365-2567.2009.03072.x. Immunology. 2009. PMID: 19689737 Free PMC article. - Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein.
Macen JL, Garner RS, Musy PY, Brooks MA, Turner PC, Moyer RW, McFadden G, Bleackley RC. Macen JL, et al. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9108-13. doi: 10.1073/pnas.93.17.9108. Proc Natl Acad Sci U S A. 1996. PMID: 8799162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous